Table 3.

MiRNAs upregulated in ovarian cancer.

Year	Tissue/Cell Type	N	miRNA	Reference
2021	Plasma EVs	34	miR-4732-5p	Liu et al. [71]
2020	Tumour & TAN, CAOV3, SKOV3	11	miR-141, miR-200a, miR-7, miR-203, miR-18a, miR-93, miR-106a, miR-20a, miR-19a	Wahab et al. [72]
2019	Serum EVs	48	miR-93, miR-145, miR-200c	Kim et al. [73]
2017	Tumour & TAN, A2780, OVCAR3, SKOV3, 3AO	63	miR-221	Li et al. [66]
2016	Tumour & TAN, SKOV3, OV56, A2780, COV362, EFO21, OV90	145	miR-760	Liao et al. [74]
2014	Tumour & TAN	487	miR-96-5p, miR-182, miR-183, miR-141-5p, miR-200a, miR-200b, miR-200c, miR-429	Wang et al. [70]
2015	Serum	180	miR-7, miR-429	Meng et al. [69]

N = number of tissue samples, TAN = tumour-associated normal, EV = extracellular vesicle.